دورية أكاديمية
Routine Vaccination Coverage - Worldwide, 2021.
العنوان: | Routine Vaccination Coverage - Worldwide, 2021. |
---|---|
المؤلفون: | Rachlin A, Danovaro-Holliday MC, Murphy P, Sodha SV, Wallace AS |
المصدر: | MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2022 Nov 04; Vol. 71 (44), pp. 1396-1400. Date of Electronic Publication: 2022 Nov 04. |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: U.S. Centers for Disease Control Country of Publication: United States NLM ID: 7802429 Publication Model: Electronic Cited Medium: Internet ISSN: 1545-861X (Electronic) Linking ISSN: 01492195 NLM ISO Abbreviation: MMWR Morb Mortal Wkly Rep Subsets: MEDLINE |
أسماء مطبوعة: | Publication: Atlanta, GA : U.S. Centers for Disease Control Original Publication: [Atlanta] U. S. Dept. of Health, Education, and Welfare, Public Health Service, Center for Disease Control. |
مواضيع طبية MeSH: | Vaccination Coverage* , COVID-19*, Infant ; Child ; Humans ; Pandemics ; Diphtheria-Tetanus-Pertussis Vaccine ; Immunization Programs ; Vaccination ; Measles Vaccine ; Rubella Vaccine ; Immunization Schedule |
مستخلص: | In 2020, the World Health Assembly endorsed the Immunization Agenda 2030, an ambitious global immunization strategy to reduce morbidity and mortality from vaccine-preventable diseases (1). This report updates a 2020 report (2) with global, regional,* and national vaccination coverage estimates and trends through 2021. Global estimates of coverage with 3 doses of diphtheria-tetanus-pertussis-containing vaccine (DTPcv3) decreased from an average of 86% during 2015-2019 to 83% in 2020 and 81% in 2021. Worldwide in 2021, 25.0 million infants (19% of the target population) were not vaccinated with DTPcv3, 2.1 million more than in 2020 and 5.9 million more than in 2019. In 2021, the number of infants who did not receive any DTPcv dose by age 12 months (18.2 million) was 37% higher than in 2019 (13.3 million). Coverage with the first dose of measles-containing vaccine (MCV1) decreased from an average of 85% during 2015-2019 to 84% in 2020 and 81% in 2021. These are the lowest coverage levels for DTPcv3 and MCV1 since 2008. Global coverage estimates were also lower in 2021 than in 2020 and 2019 for bacillus Calmette-Guérin vaccine (BCG) as well as for the completed series of Haemophilus influenzae type b vaccine (Hib), hepatitis B vaccine (HepB), polio vaccine (Pol), and rubella-containing vaccine (RCV). The COVID-19 pandemic has resulted in disruptions to routine immunization services worldwide. Full recovery to immunization programs will require context-specific strategies to address immunization gaps by catching up missed children, prioritizing essential health services, and strengthening immunization programs to prevent outbreaks (3). Competing Interests: All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed. |
References: | Bull World Health Organ. 2009 Jul;87(7):535-41. (PMID: 19649368) World Health Stat Q. 1988;41(2):59-63. (PMID: 3176515) Lancet Glob Health. 2022 Feb;10(2):e186-e194. (PMID: 34951973) Bull World Health Organ. 2020 Feb 1;98(2):146-148. (PMID: 32015586) MMWR Morb Mortal Wkly Rep. 2021 Oct 29;70(43):1495-1500. (PMID: 34710074) |
المشرفين على المادة: | 0 (Diphtheria-Tetanus-Pertussis Vaccine) 0 (Measles Vaccine) 0 (Rubella Vaccine) |
تواريخ الأحداث: | Date Created: 20221103 Date Completed: 20221107 Latest Revision: 20221118 |
رمز التحديث: | 20240628 |
مُعرف محوري في PubMed: | PMC9639437 |
DOI: | 10.15585/mmwr.mm7144a2 |
PMID: | 36327156 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1545-861X |
---|---|
DOI: | 10.15585/mmwr.mm7144a2 |